Systemic therapy with oncolytic myxoma virus cures established residual multiple myeloma in mice

Multiple myeloma is an incurable malignancy of plasma B-cells. Traditional chemotherapeutic regimes often induce initial tumor regression; however, virtually all patients eventually succumb to relapse caused by either reintroduction of disease during autologous transplant or expansion of chemotherap...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartee, Eric, Bartee, Mee Y, Bogen, Bjarne, Yu, Xue-Zhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5142464/
https://www.ncbi.nlm.nih.gov/pubmed/27933316
http://dx.doi.org/10.1038/mto.2016.32

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5142464/
https://www.ncbi.nlm.nih.gov/pubmed/27933316
http://dx.doi.org/10.1038/mto.2016.32

Ejemplares similares